Cancer Institute– A national cancer institute
designated cancer center

Ellen Chang

Back to Profile

Publication Details

  • Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.

    Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, Sørensen KM, Porwit A, Humphreys K, Melbye M, Ekström Smedby K. Cancer Causes Control. 2010; 21 (5): 759-69

    Tumor necrosis factor (TNF) and interleukin 10 (IL10) are promising candidate susceptibility genes for non-Hodgkin lymphoma (NHL). Chromosomal translocation breakpoint genes are of interest, given their documented involvement in lymphoma progression.

    PubMedID: 20087644

Stanford Medicine Resources:

Footer Links: